Are you Dr. Freeman?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 56 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1414 Yanceyville St
Greensboro, NC 27405Phone+1 336-574-8000Fax+1 336-574-8008
Summary
- Dr. Marshall Freeman, MD is a board certified neurologist in Greensboro, North Carolina. He is currently licensed to practice medicine in North Carolina, New Jersey, and Michigan.
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Clinical Neurophysiology, 1999 - 2001
- New York Presbyterian Hospital (Cornell Campus)Residency, Neurology, 1996 - 1999
- Corewell Health East Beaumont (Dearborn & Taylor)Internship, Transitional Year, 1995 - 1996
- Wayne State University School of MedicineClass of 1995
Certifications & Licensure
- NC State Medical License 2002 - 2025
- MI State Medical License 2000 - 2007
- NJ State Medical License 2001 - 2003
- NY State Medical License 1999 - 2002
- American Board of Psychiatry and Neurology Neurology
- American Board of Psychiatry and Neurology Neuromuscular Medicine
- National Board of Physicians and Surgeons Neurology
- National Board of Physicians and Surgeons Neuromuscular Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification PrimeSUITE EHR, Greenway Health, LLC, 2011-2013
Clinical Trials
- A Non-Invasive Neuromodulation Device for Treatment of Migraine Headache Start of enrollment: 2013 Aug 01
Publications & Presentations
PubMed
- 203 citationsOnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Analyses of the 56-Week PREEMPT Clinical ProgramSheena K. Aurora, Paul Winner, Marshall C. Freeman, Egilius L.H. Spierings, Jessica O. Heiring
Headache. 2011-10-01 - 37 citationsPreventing Episodic Migraine With Caloric Vestibular Stimulation: A Randomized Controlled TrialDavid T. Wilkinson, Kristen K. Ade, Lesco L. Rogers, Deborah K. Attix, Maragatha Kuchibhatla
Headache. 2017-07-01 - 114 citationsLong-term study of the efficacy and safety of OnabotulinumtoxinA for the prevention of chronic migraine: COMPEL studyAndrew M. Blumenfeld, Richard J Stark, Marshall C. Freeman, Amelia Orejudos, Aubrey Manack Adams
The Journal of Headache and Pain. 2018-02-05